Randomized Control Trial for suppression of perioperative bleeding byetween tranexamic acid and surge cell.

Randomized Control Trial for suppression of perioperative bleeding byetween tranexamic acid and surge cell. - Randomized Control Trial for suppression of perioperative bleeding byetween tranexamic acid and surge cell.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047607

Enrollment

100

Registered

2022-05-07

Start date

2022-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Control : Tranexamic Acid 1-2g Intervention : Surgi-cell less than 3g

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Osteoarthritis of the Knee or Hip

Exclusion criteria

Exclusion criteria: Other than osteoarthritis, History of spine, hip, knee surgery, bilateral simultaneous THA or TKA, contralateral THA within 1 year after surgery / spine surgery / lower limb surgery / reoperation, stroke / neuromuscular disease paralysis

Design outcomes

Primary

Measure	Time frame
Estimated Blood loss	—

Countries

Japan

Contacts

Public ContactKentaro Iwakiri

Shiraniwa Hospital Orthopaedic Surgery

kenpiecekenpiece@yahoo.co.jp0743-70-0022

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026